Solamargine
CAS No. 20311-51-7
Solamargine( Solamargin | δ-Solanigrine )
Catalog No. M17419 CAS No. 20311-51-7
Solamargine is a major steroidal alkaloid glycoside extracted from a traditional Chinese medicine herb, Solanum nigrum L. (SNL); has been shown to inhibit growth and induce apoptosis of various cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 105 | In Stock |
|
| 10MG | 159 | In Stock |
|
| 25MG | 327 | In Stock |
|
| 50MG | 506 | In Stock |
|
| 100MG | 711 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSolamargine
-
NoteResearch use only, not for human use.
-
Brief DescriptionSolamargine is a major steroidal alkaloid glycoside extracted from a traditional Chinese medicine herb, Solanum nigrum L. (SNL); has been shown to inhibit growth and induce apoptosis of various cancer cells.
-
DescriptionSolamargine is a major steroidal alkaloid glycoside extracted from a traditional Chinese medicine herb, Solanum nigrum L. (SNL); has been shown to inhibit growth and induce apoptosis of various cancer cells.
-
In VitroSolamargine (15 μg/ml; 72 hours) predominantly stimulates the cells of the G2/M phase to apoptosis.Solamargine (72 hours) dramatically inhibits the proliferation of SMMC-7721 and HepG2 cells in a dose- and time-dependent manner. The IC50s are 9.21 and 19.88 μg/ml, respectively. Cell Viability Assay Cell Line:SMMC-7721cells Concentration:15 μg/ml.Incubation Time:72 hours Result:Displayed a significant increase of sub-G1.
-
In VivoSolamargine (10 mg/kg; intragastric administration; once daily for 8 days) exhibits an antitumor effect and promotes the apoptosis of GC in vivo. Animal Model:Female specific pathogen-free BALB/c nude mice weighing 18-20 g (6-8-weeks-old) Dosage:10 mg/kg Administration:Intragastric administration; once daily for 8 days Result:Tumor growth was significantly inhibited .
-
SynonymsSolamargin | δ-Solanigrine
-
PathwayAngiogenesis
-
TargetPKC
-
Recptorp38 MAPK| STAT3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number20311-51-7
-
Formula Weight868.07
-
Molecular FormulaC45H73NO15
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 8.8 mg/mL; 10.14 mM
-
SMILES[C@H]1([C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@]6([C@H]([C@@H]5[C@]4(CC[C@@H]3[C@]2(CC1)C)C)C)NC[C@@H](CC6)C)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sani IK., et al. Toxicol In Vitro. 2015 Aug;29(5):893-900.
molnova catalog
related products
-
Ruboxistaurin hydroc...
A potent, selective, ATP-competitive, orally available PKC beta (PKCβ) inhibitor with IC50 of 4.7 and 5.9 nM for PKCβ I and PKCβ II, respectively.
-
PKCiota-IN-49
PKCiota-IN-49 is a potent and selective inhibitor of Protein Kinase C iota (PKC-ι) with IC50 of 2.8 nM.
-
Coptisine chloride
Coptisine chloride can be absorbed across intestinal epithelial cells, and completely absorbed compounds.
Cart
sales@molnova.com